Scarica l'app Stockscreener
26.78
0.48%
-0.13
Dopo l'orario di chiusura:
26.87
0.09
+0.34%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché ACAD Giù?
Forum
Previsione
Acadia Pharmaceuticals Inc Borsa (ACAD) Ultime notizie
Can ACADIA Pharmaceuticals Inc. stock attract ESG capital inflows2025 Analyst Calls & Growth Focused Stock Pick Reports - ulpravda.ru
How ACADIA Pharmaceuticals Inc. stock compares to industry benchmarks2025 Market Outlook & AI Driven Stock Reports - ulpravda.ru
Acadia drops development of carbetocin in PWS - The Pharma Letter
Pullback Watch: Will ACADIA Pharmaceuticals Inc. stock outperform international peersJuly 2025 Review & Fast Gain Stock Trading Tips - ulpravda.ru
Will ACADIA Pharmaceuticals Inc. stock beat EPS estimatesProduct Launch & Risk Adjusted Swing Trade Ideas - ulpravda.ru
Is ACADIA Pharmaceuticals Inc. stock a defensive play in 2025Forecast Cut & Free Reliable Trade Execution Plans - ulpravda.ru
Stock Market Recap: Will ACADIA Pharmaceuticals Inc. stock outperform international peersJuly 2025 Drop Watch & AI Powered Buy and Sell Recommendations - ulpravda.ru
Assessing ACADIA Pharmaceuticals (ACAD) Valuation After Recent Share Price Momentum - Sahm
ACADIA Pharmaceuticals (ACAD) Sees Target Price Raised by Citigr - GuruFocus
UBS Raises Price Target to $40 for ACADIA Pharmaceuticals (ACAD) - GuruFocus
ACADIA Pharmaceuticals Inc. $ACAD Shares Purchased by Allspring Global Investments Holdings LLC - MarketBeat
ACADIA Pharmaceuticals (NASDAQ:ACAD) Cut to "Hold" at Wall Street Zen - MarketBeat
What drives ACADIA Pharmaceuticals Inc stock priceMean Reversion Trades & Outstanding Wealth Building - earlytimes.in
ACADIA Pharmaceuticals Earnings Notes - Trefis
Insider Sell: Is ACADIA Pharmaceuticals Inc stock in correction or buying zoneIndex Update & Risk Controlled Swing Alerts - moha.gov.vn
(ACAD) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily
Deutsche Bank Upgrades ACADIA Pharmaceuticals (ACAD) - MSN
Performance Recap: Can ACADIA Pharmaceuticals Inc stock hit analyst price targetsWeekly Earnings Recap & Verified Swing Trading Watchlists - moha.gov.vn
Rice Hall James & Associates LLC Sells 54,869 Shares of ACADIA Pharmaceuticals Inc. $ACAD - MarketBeat
ACADIA Pharmaceuticals Inc. $ACAD Holdings Decreased by Assenagon Asset Management S.A. - MarketBeat
Acadia Stock Up 59% in a Year — Is a $51 Million New Stake a Bet on a Bigger Rebound? - AOL.com
Here's why Acadia Pharmaceuticals (ACAD) is a strong momentum stock - MSN
ACADIA Pharmaceuticals Advances Alzheimer’s Disease Psychosis Study with ACP-204 - MSN
Here's Why Acadia Pharmaceuticals (ACAD) is a Strong Momentum Stock - sharewise.com
Acadia Pharmaceuticals stock reaches 52-week high at $27.73 By Investing.com - Investing.com Nigeria
ACADIA Pharmaceuticals (NASDAQ:ACAD) Hits New 1-Year HighHere's Why - MarketBeat
Acadia Pharmaceuticals stock reaches 52-week high at $27.73 - Investing.com
Acadia Pharmaceuticals price target raised to $29 from $24 at Mizuho - MSN
Assessing ACADIA Pharmaceuticals (ACAD) Valuation After Its Strong 1-Year Share Price Rally - Yahoo Finance
Can ACADIA Pharmaceuticals Inc. stock maintain growth trajectoryWeekly Trading Summary & Reliable Breakout Stock Forecasts - Улправда
How ACADIA Pharmaceuticals Inc. stock compares to growth peers2025 EndofYear Setup & Weekly High Return Forecasts - ulpravda.ru
Market Recap: How ACADIA Pharmaceuticals Inc. stock compares to growth peersJuly 2025 Setups & Community Verified Trade Signals - Улправда
Can ACADIA Pharmaceuticals Inc. stock hit analyst price targets2025 Major Catalysts & Precise Buy Zone Identification - DonanımHaber
Will ACADIA Pharmaceuticals Inc. stock see PE expansionWeekly Trend Report & High Conviction Trade Alerts - DonanımHaber
Acadia Pharmaceuticals to Present at the 44th Annual J.P. Morgan Healthcare Conference on January 13, 2026 - Yahoo Finance
Is ACADIA Pharmaceuticals Inc. stock a good choice for value investorsQuarterly Portfolio Summary & Safe Capital Growth Trade Ideas - Улправда
What is HC Wainwright's Forecast for ACAD FY2028 Earnings? - MarketBeat
FDA approves Acadia’s Daybue Stix for Rett syndrome - MSN
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Given Consensus Rating of "Moderate Buy" by Analysts - MarketBeat
Stifel maintains ACADIA Pharmaceuticals (ACAD) hold recommendation - MSN
New DAYBUE STIX Rett Syndrome Formulation Might Change The Case For Investing In ACADIA Pharmaceuticals (ACAD) - simplywall.st
Acadia Pharmaceuticals stock price target raised to $37 by H.C. Wainwright - Investing.com
ACADIA Pharmaceuticals Inc. $ACAD Stock Position Trimmed by Hudson Bay Capital Management LP - MarketBeat
Neuren partner Acadia bags FDA go-ahead for new DAYBUE STIX powder for Rett Syndrome - Indian Pharma Post
ACAD Sees Boost in Price Target by HC Wainwright & Co. | ACAD St - GuruFocus
Neuren Pharmaceuticals’ partner Acadia gains FDA approval for new Rett syndrome treatment - MSN
FDA Approves Acadia Pharmaceuticals’ Daybue Stix for Treating Rett Syndrome - geneonline.com
FDA approves Acadia’s Daybue Stix for Rett syndrome treatment - Pharmaceutical Technology
0.90%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):